Clinical trial
Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder)…
NCT00108420 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00108420 |
|---|---|
| Title | Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance |
| Official title | Prazosin Treatment for Combat Trauma PTSD Nightmares and Sleep Disturbance |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Stress Disorder, Post-Traumatic |
| Intervention type | Drug |
| Interventions | Prazosin |
| Start date | Oct 1, 2003 |
| Completion | Mar 1, 2007 |
| First posted | Apr 15, 2005 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: